The intersection of artificial intelligence and biotechnology presents one of the most profound dual-use dilemmas of our time. While AI models like AlphaFold have revolutionized our understanding of protein structures—offering unprecedented potential to cure chronic diseases and cancers—the same technology can theoretically be weaponized to engineer synthetic pathogens. This terrifying possibility was recently brought to…